Shopping Cart
- Remove All
- Your shopping cart is currently empty
SHP389 is a highly effective allosteric inhibitor of SHP2, inhibiting SHP2 and p-ERK, used in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $165 | In Stock | |
5 mg | $413 | In Stock | |
10 mg | $689 | In Stock | |
25 mg | $1,490 | In Stock | |
50 mg | $2,480 | In Stock | |
1 mL x 10 mM (in DMSO) | $455 | In Stock |
Description | SHP389 is a highly effective allosteric inhibitor of SHP2, inhibiting SHP2 and p-ERK, used in cancer research. |
Targets&IC50 | SHP2:36 nM |
In vitro | SHP389 is an allosteric inhibitor of SHP2 with IC50 of 36 nM for SHP2. SHP389 showed high clearance in rat liver microsomes in vitro (Cl = 26.1 μL/min/mg, T1/2 = 53.2 min), large distribution volume (3.9 L/kg), terminal half-life of 2.7 h, and oral bioavailability of 2%. [2] |
In vivo | SHP389 modulates MAPK signaling in vivo[1]. |
Alias | SHP 389 |
Molecular Weight | 484.98 |
Formula | C23H29ClN8O2 |
Cas No. | 2235394-90-6 |
Smiles | N[C@H]1C2(CCN(CC2)C3=NC=4C(C(=O)N3C)=C(NN4)C=5C(Cl)=C(NC6CC6)N=CC5)CO[C@H]1C |
Relative Density. | 1.67 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (164.96 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.